Cancer Drug Makers Seek 50% Price Hike Amid Platinum Surge
06 Apr 2026 //
ECONOMICTIMES
Denali Regains Full Rights to Investigational Therapy DNL593
06 Apr 2026 //
GLOBENEWSWIRE
Sun Pharma Advances New Phase III Study In Soft Tissue Sarcoma
06 Apr 2026 //
INDPHARMAPOST
Weight-Loss Injections Integrated Into Indian `Mounjaro Brides`
06 Apr 2026 //
ECONOMICTIMES
Neurocrine expands into metabolic diseases with $2.9 billion Sole
06 Apr 2026 //
REUTERS
Trump Eyes 100% Tariff Rate For Imported Drugs
06 Apr 2026 //
FIERCE PHARMA
Lupin Completes Acquisition Of Visufarma
06 Apr 2026 //
PHARMIWEB
India Pushes Biosimilar Insulin Scale-Up Amid Supply Concerns
05 Apr 2026 //
INDPHARMAPOST
Sun Pharma Appoints Satyavati Berera As Independent Director
05 Apr 2026 //
INDPHARMAPOST
Drugs In Development
Market Intel

Market Place
Sourcing Support